12
Israel-India Business Guide - MedTech, Pharma & Biotech
Providing Opportunities
for interaction between
industry and policy makers
FICCI Life Sciences works closely with the government on
policy issues, enhancing efficiency, competitiveness and
expanding business opportunities for industry through
a range of specialized services and global linkages. It
also provides a platform for sector specific consensus
building and networking. It has been actively involved
in organizing conferences and seminars, providing an
opportunity for interaction between the industry and
the policy makers, to identify the various impediments
to the growth and functioning of the industry and to
come out with prospective solutions for the same.
FICCI Life Sciences comprises of three major sectors:
Biotechnology
FICCI has led an initiative of formulating Biotechnology
Committee. First Biotech Committee Meeting was held
on 12th April, 2011 where in several issues has been
discussed. Committee is still in the process of identifying
policy issues within the Sector. The issues which have
which has been identified and deliberated in the first
meeting are as under:
• Engage with DCGI and other concerned officials: to Map
out the hurdles in the process of Product clearances
• Emphasis on Industry- Academia bridging: to gaps
between Industry and Academia
• Emphasis on the funding programs: to improvisation of
the Government Funding Schemes and awareness
• Revive the Industry platform: to bridge the gap by
bringing together industry, academia, policy planners
and all other stakeholders to define and implement
an industry driven research agenda, provides industry
an opportunity to contribute ideas for public funded
research
Apart from the above identified issues FICCI is also focusing
on three major areas in the Biotech Sector:
• Similar Biologics/Biosimilars
• Vaccines
• Stem Cells
• Clinical Research
FICCI Taskforce on Clinical Research works closely with
government on policy issues, enhancing efficiency,
competitiveness and expanding business opportunities for
Clinical Research Industry.
FICCI had led the initiative with support of government
to highlight the strengths and potential of Indian Clinical
Research Industry by participating in 45th Annual DIA
Meeting, in San Diego, USA, and organized various India-
focused programmes.
Pharmaceuticals
FICCI in partnership with the Department of
Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers
organizes the "India Pharma Summit", an annual event
of the DoP. This event provides a platform to the various
stakeholders to address key issues, identify challenges
and chart a road map for India to take a rightful place
as a destination of choice Drug Discovery, Research &
Development, Manufacturing and realize its full potential
to become globally competitive.
India Pharma Summit, March 20, 2014-Mumbai
Dr. Arbind Prasad, Director General, FICCI at India
Pharma Summit, March 20, 2014 in Mumbai
Overview of Life Sciences Sector of FICCI
MedTech